EU-PRODUCT_SAFETY-ART_2
EU-PRODUCT_SAFETY-ART_2
General Product Safety Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of General Product Safety Directive (2001/95/EC), 15 January 2002, amended by Reg 596/2009/EC, 18 July 2009
This list contains a non-exhaustive inventory of substances that fall within the European Union's hazardous substance definitions, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; (2) Annex III of Directive 2000/54/EC (Biological Agents); Candidate List of SVHCs; and REACH Annexes XIV and XVII (Authorisation and Restriction lists). They can be considered hazardous for purposes of the General Product Safety Directive 2001/95/EC.
Last updated 15 listopada 2024. Database contains 5505 unique substances/entries.
Filter the list
|
Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30°C to 180°C (86°F to 356°F). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.
|
302-691-7
|
94114-55-3
|
yes |
Annex 17 Appendix 2 |
|||
|
A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20°C to 120°C (-4°F to 248°F).
|
232-349-1
|
8006-61-9
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
|||
|
A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.
|
271-726-5
|
68606-10-0
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
|||
|
A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20°C to 200°C (68°F to 392°F).
|
302-639-3
|
94114-03-1
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
|||
|
A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36.1°C to 193.3°C (97°F to 380°F).
|
271-727-0
|
68606-11-1
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
|||
|
A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 196°C(-4°F to 384°F).
|
271-025-4
|
68514-15-8
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
|||
|
A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30°C to 260°C (86°F to 500°F).
|
289-220-8
|
86290-81-5
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
|||
|
203-377-1
|
106-24-1
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
P Parasites |
|||||
|
-
|
-
|
yes |
|||||
|
232-589-7
|
9001-22-3
|
yes |
|||||
|
278-636-5
|
77182-82-2
|
yes |
Annex 17 Appendix 6 |
||||
|
EW 400; GLUCOPROTAMIN
|
403-950-8
|
164907-72-6
|
yes |
||||
|
203-856-5
|
111-30-8
|
yes |
yes |
||||
|
200-240-8
|
55-63-0
|
yes |
|||||
|
200-240-8
|
55-63-0
|
yes |
|||||
|
203-474-9
|
107-22-2
|
yes |
|||||
|
206-058-5
|
298-12-4
|
yes |
|||||
|
213-997-4
|
1071-83-6
|
yes |
|||||
|
617-243-9
|
81591-81-3
|
yes |
|||||
|
219-468-4
|
2439-99-8
|
yes |
|||||
|
231-159-6
|
7440-50-8
|
yes |
|||||
|
201-964-7
|
90-05-1
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
GUANIDINIUMBENZOAT
|
429-820-0
|
26739-54-8
|
yes |
||||
|
200-002-3
|
50-01-1
|
yes |
|||||
|
620-427-1
|
108173-90-6
|
yes |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
TILCOM HTB
|
411-740-2
|
22411-22-9
|
yes |
||||
|
600-130-3
|
100784-20-1
|
yes |
Annex 17 Appendix 6 |
||||
|
HALOXYFOP ETHOXYETHYL EST
|
402-560-5
|
87237-48-7
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
12035-71-1
|
yes |
Annex 17 Appendix 1 |
||||
|
-
|
-
|
B Bacteria and similar species |
|||||
|
218-165-4
|
2058-94-8
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
200-962-3
|
76-44-8
|
yes |
|||||
|
213-831-0
|
1024-57-3
|
yes |
|||||
|
206-803-4
|
376-06-7
|
yes |
|||||
|
203-767-1
|
110-43-0
|
yes |
|||||
|
203-388-1
|
106-35-4
|
yes |
|||||
|
204-608-9
|
123-19-3
|
yes |
|||||
|
205-563-8
|
142-82-5
|
yes |
|||||
|
203-838-7
|
111-14-8
|
yes |
|||||
|
245-737-0
|
23560-59-0
|
yes |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||
|
204-129-5
|
116-16-5
|
yes |
|||||
|
204-273-9
|
118-74-1
|
yes |
Annex 17 Appendix 2 |
||||
|
201-029-3
|
77-47-4
|
yes |
|||||
|
200-666-4
|
67-72-1
|
Annex 17 |
|||||
|
show/hide
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
EC / List no:
271-555-6
| CAS no:
68585-32-0
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with tributylphosphine hydrochloride and N-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
EC / List no:
-
| CAS no:
67924-25-8
Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane
EC / List no:
258-092-5
| CAS no:
52672-74-9
Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium
EC / List no:
-
| CAS no:
68516-04-1
|
-
|
-
|
yes |
||||
|
241-010-7
|
16941-12-1
|
yes |
|||||
|
HEXACONAZOLE
|
413-050-7
|
79983-71-4
|
yes |
||||
|
424-830-1
|
220229-87-8
|
yes |
|||||
|
428-140-1
|
210706-50-6
|
yes |
|||||
|
C-1742
|
418-550-9
|
168689-49-4
|
yes |
||||
|
401-400-1
|
86479-06-3
|
yes |
|||||
|
204-127-4
|
116-15-4
|
yes |
|||||
|
256-356-4
|
48122-14-1
|
yes |
yes |
||||
|
260-566-1
|
57110-29-9
|
yes |
yes |
||||
|
243-072-0
|
19438-60-9
|
yes |
yes |
||||
|
AMINAZA TOLFAMATATE
|
418-350-1
|
-
|
yes |
||||
|
247-094-1
|
25550-51-0
|
yes |
yes |
||||
|
DIRECT RED 227, TETRAMETHYLAMMONIUM SALT
|
405-160-9
|
124537-30-0
|
yes |
||||
|
235-921-9
|
13048-33-4
|
yes |
|||||
|
212-485-8
|
822-06-0
|
yes |
|||||
|
204-679-6
|
124-09-4
|
yes |
|||||
|
211-653-8
|
680-31-9
|
yes |
Annex 17 Appendix 2; Annex 17 Appendix 4 |
||||
|
203-852-3
|
111-27-3
|
yes |
|||||
|
209-731-1
|
591-78-6
|
yes |
|||||
|
-
|
-
|
yes |
|||||
|
247-143-7
|
25637-27-8
|
yes |
|||||
|
PROCION EMERALD H-EXL COLOUR; SUBSTANCE S156718
|
417-250-5
|
151436-99-6
|
yes |
||||
|
C.I. REACTIVE BLUE 217
|
412-240-7
|
89797-03-5
|
yes |
||||
|
BRIGHTENER SM 1018 CONC.; LEUCOPHOR BCR
|
405-280-1
|
76508-02-6
|
yes |
||||
|
RED SF-PE 3534
|
410-180-6
|
157627-99-1
|
yes |
||||
|
C.I. BLEU REACTIF 204; C.I. REACTIVE BLUE 204; REACTIVE BLUE 204; REAKTIV BLAU 204
|
400-050-7
|
85153-92-0
|
yes |
||||
|
BRUN REACTIF 45; BRUNO REATTIVO 45; C.I. REACTIVE BROWN 45; CIBACROM BROWN 1347; CIBACRON BROWN 1347; REACTIVE BRAUN 45
|
401-650-1
|
85665-96-9
|
yes |
||||
|
BROWN MO 384; BRUN MO 384; INDOSOL BRAUN SF-BR; INDOSOL BROWN SF-BR; INDOSOL BRUIN SF-BR
|
400-020-3
|
82027-60-9
|
yes |
||||
|
NATRIUMMETAWOLFRAMAT
|
412-770-9
|
12141-67-2
|
yes |
||||
|
257-074-4
|
51235-04-2
|
yes |
|||||
|
219-698-5
|
2499-95-8
|
yes |
|||||
|
616-638-3
|
78587-05-0
|
yes |
|||||
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
F Fungi |
|||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||||